Copper accumulation by cultured astrocytes

Neurochemistry International

Volumn 56, Issue 3, 2010, Pages 451-460

  Scheiber, Ivo F ^a   Mercer, Julian F B ^b   Dringen, Ralf ^a,c  

^a UNIVERSITY OF BREMEN   (Germany)

^b DEAKIN UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Ascorbate; Ctr1; Cupri reductase; Metal ions; Transport

Indexed keywords

ASCORBIC ACID; CARRIER PROTEIN; COPPER; COPPER CHLORIDE; COPPER TRANSPORT RECEPTOR 1; MESSENGER RNA; METAL ION; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL KINETICS; CELL LEVEL; CELL METABOLISM; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; COPPER METABOLISM; IMMUNOREACTIVITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ANIMALS; ANIMALS, NEWBORN; ASCORBIC ACID; ASTROCYTES; BIOLOGICAL TRANSPORT, ACTIVE; BRAIN; BRAIN CHEMISTRY; CATION TRANSPORT PROTEINS; CELLS, CULTURED; CHLORIDES; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; KINETICS; MALE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 77049112979     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.12.002     Document Type: Article

References (80)

1. Aller S.G., Unger V.M. Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3627-3632.
2. Arredondo M., Munoz P., Mura C.V., Nunez M.T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 2003, 284:C1525-C1530.
3. Aschner M., Cherian M.G., Klaassen C.D., Palmiter R.D., Erickson J.C., Bush A.I. Metallothioneins in brain-the role in physiology and pathology. Toxicol. Appl. Pharmacol. 1997, 142:229-242.
4. Balamurugan K., Schaffner W. Copper homeostasis in eukaryotes: teetering on a tightrope. Biochim. Biophys. Acta 2006, 1763:737-746.
5. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80:1326-1338.
6. Brown D.R. Role of the prion protein in copper turnover in astrocytes. Neurobiol. Dis. 2004, 15:534-543.
7. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 2001, 66:1198-1207.
8. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
9. Darwish H.M., Hoke J.E., Ettinger M.J. Kinetics of Cu(II) transport and accumulation by hepatocytes from copper-deficient mice and the brindled mouse model of Menkes disease. J. Biol. Chem. 1983, 258:13621-13626.
10. De Feo C.J., Aller S.G., Siluvai G.S., Blackburn N.J., Unger V.M. Three-dimensional structure of the human copper transporter hCTR1. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4237-4242.
11. De Feo C.J., Aller S.G., Unger V.M. A structural perspective on copper uptake in eukaryotes. Biometals 2007, 20:705-716.
12. Demeuse P., Kerkhofs A., Struys-Ponsar C., Knoops B., Remacle C., van den Bosch de Aguilar P. Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood-brain barrier. J. Neurosci. Methods 2002, 121:21-31.
13. Dineley K.E., Scanlon J.M., Kress G.J., Stout A.K., Reynolds I.J. Astrocytes are more resistant than neurons to the cytotoxic effects of increased [Zn(2+)](i). Neurobiol. Dis. 2000, 7:310-320.
14. Dringen R., Hamprecht B. Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev. Neurosci. 1998, 20:401-407.
15. Dringen R., Pfeiffer B., Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 1999, 19:562-569.
16. Eide D.J. Zinc transporters and the cellular trafficking of zinc. Biochim. Biophys. Acta 2006, 1763:711-722.
17. Eisses J.F., Chi Y., Kaplan J.H. Stable plasma membrane levels of hCTR1 mediate cellular copper uptake. J. Biol. Chem. 2005, 280:9635-9639.
18. Eisses J.F., Kaplan J.H. Molecular characterization of hCTR1, the human copper uptake protein. J. Biol. Chem. 2002, 277:29162-29171.
19. Erikson K.M., Aschner M. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology 2006, 27:125-130.
20. Ferretti G., Bacchetti T., Moroni C., Vignini A., Curatola G. Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim. Biophys. Acta 2003, 1635:48-54.
21. Ferruzza S., Scarino M.L., Rotilio G., Ciriolo M.R., Santaroni P., Muda A.O., Sambuy Y. Copper treatment alters the permeability of tight junctions in cultured human intestinal Caco-2 cells. Am. J. Physiol. 1999, 277:G1138-G1148.
22. Forte G., Bocca B., Senofonte O., Petrucci F., Brusa L., Stanzione P., Zannino S., Violante N., Alimonti A., Sancesario G. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J. Neural Transm. 2004, 111:1031-1040.
23. Gaeta A., Hider R.C. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br. J. Pharmacol. 2005, 146:1041-1059.
24. Gaither L.A., Eide D.J. Functional expression of the human hZIP2 zinc transporter. J. Biol. Chem. 2000, 275:5560-5564.
25. Gaither L.A., Eide D.J. The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells. J. Biol. Chem. 2001, 276:22258-22264.
26. Girijashanker K., He L., Soleimani M., Reed J.M., Li H., Liu Z., Wang B., Dalton T.P., Nebert D.W. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol. Pharmacol. 2008, 73:1413-1423.
27. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
28. Guo Y., Smith K., Lee J., Thiele D.J., Petris M.J. Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J. Biol. Chem. 2004, 279:17428-17433.
29. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13:54-63.
30. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990, 186:1-85.
31. Hamprecht B., Loffler F. Primary glial cultures as a model for studying hormone action. Methods Enzymol. 1985, 109:341-345.
32. Harada M. Wilson disease. Med. Electr. Microsc. 2002, 35:61-66.
33. Hardman B., Manuelpillai U., Wallace E.M., Monty J.F., Kramer D.R., Kuo Y.M., Mercer J.F., Ackland M.L. Expression, localisation and hormone regulation of the human copper transporter hCTR1 in placenta and choriocarcinoma Jeg-3 cells. Placenta 2006, 27:968-977.
34. Haydon P.G., Blendy J., Moss S.J., Rob Jackson F. Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?. Neuropharmacology 2009, 56(Suppl 1):83-90.
35. Haywood S., Paris J., Ryvar R., Botteron C. Brain copper elevation and neurological changes in north Ronaldsay sheep: a model for neurodegenerative disease?. J. Comp. Pathol. 2008, 139:252-255.
36. Hopt A., Korte S., Fink H., Panne U., Niessner R., Jahn R., Kretzschmar H., Herms J. Methods for studying synaptosomal copper release. J. Neurosci. Methods 2003, 128:159-172.
37. Huidobro-Toro J.P., Lorca R.A., Coddou C. Trace metals in the brain: allosteric modulators of ligand-gated receptor channels, the case of ATP-gated P2X receptors. Eur. Biophys. J. 2008, 37:301-314.
38. Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 2003, 278:27144-27148.
39. Kambe T., Yamaguchi-Iwai Y., Sasaki R., Nagao M. Overview of mammalian zinc transporters. Cell Mol. Life Sci. 2004, 61:49-68.
40. Kim B.E., Nevitt T., Thiele D.J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 2008, 4:176-185.
41. Kodama H., Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr. Int. 1999, 41:430-435.
42. Leberman R., Rabin B.R. Multiplicity of histidine-Cu(II) complexes. Nature 1959, 183:746-747.
43. Lech T., Sadlik J.K. Copper concentration in body tissues and fluids in normal subjects of southern Poland. Biol. Trace Elem. Res. 2007, 118:10-15.
44. Lee J., Pena M.M., Nose Y., Thiele D.J. Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 2002, 277:4380-4387.
45. Lee J., Petris M.J., Thiele D.J. Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J. Biol. Chem. 2002, 277:40253-40259.
46. Letelier M.E., Martinez M., Gonzalez-Lira V., Faundez M., Aracena-Parks P. Inhibition of cytosolic glutathione S-transferase activity from rat liver by copper. Chem. Biol. Interact. 2006, 164:39-48.
47. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
48. Lutsenko S., Barnes N.L., Bartee M.Y., Dmitriev O.Y. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 2007, 87:1011-1046.
49. Mackenzie B., Takanaga H., Hubert N., Rolfs A., Hediger M.A. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 2007, 403:59-69.
50. Mackenzie B., Ujwal M.L., Chang M.H., Romero M.F., Hediger M.A. Divalent metal-ion transporter DMT1 mediates both H+-coupled Fe2+ transport and uncoupled fluxes. Pflugers Arch. 2006, 451:544-558.
51. Macreadie I.G. Copper transport and Alzheimer's disease. Eur. Biophys. J. 2008, 37:295-300.
52. Maryon E.B., Molloy S.A., Zimnicka A.M., Kaplan J.H. Copper entry into human cells: progress and unanswered questions. Biometals 2007, 20:355-364.
53. Mercer J.F. The molecular basis of copper-transport diseases. Trends Mol. Med. 2001, 7:64-69.
54. Muyderman H., Wadey A.L., Nilsson M., Sims N.R. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes. J. Neurochem. 2007, 102:1369-1382.
55. Nalbandyan R.M. Copper in brain. Neurochem. Res. 1983, 8:1211-1232.
56. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003, 26:523-530.
57. Nischwitz V., Berthele A., Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal. Chim. Acta 2008, 627:258-269.
58. Pamp K., Bramey T., Kirsch M., De Groot H., Petrat F. NAD(H) enhances the Cu(II)-mediated inactivation of lactate dehydrogenase by increasing the accessibility of sulfhydryl groups. Free Radic. Res. 2005, 39:31-40.
59. Perrin D.D. Histidine-copper(II) complexes. Nature 1959, 184(Suppl. 24):1868-1869.
60. Petris M.J., Smith K., Lee J., Thiele D.J. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem. 2003, 278:9639-9646.
61. Pope S.A., Milton R., Heales S.J. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem Res. 2008, 33:1410-1418.
62. Qian Y., Tiffany-Castiglioni E., Harris E.D. Copper transport and kinetics in cultured C6 rat glioma cells. Am. J. Physiol. 1995, 269:C892-C898.
63. Reddy P.V., Rao K.V., Norenberg M.D. The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab Invest. 2008, 88:816-830.
64. Rongzhu L., Suhua W., Guangwei X., Chunlan R., Fangan H., Junjie J., Aschner M. Zinc, copper, iron, and selenium levels in brain and liver of mice exposed to acrylonitrile. Biol. Trace Elem. Res. 2009, 130:39-47.
65. Rossi L., Lombardo M.F., Ciriolo M.R., Rotilio G. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem. Res. 2004, 29:493-504.
66. Sacher A., Cohen A., Nelson N. Properties of the mammalian and yeast metal-ion transporters DCT1 and Smf1p expressed in Xenopus laevis oocytes. J. Exp. Biol. 2001, 204:1053-1061.
67. Sanchez-Alvarez R., Tabernero A., Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J. Neurochem. 2004, 89:703-714.
68. Schwerdtle T., Hamann I., Jahnke G., Walter I., Richter C., Parsons J.L., Dianov G.L., Hartwig A. Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol. Nutr. Food Res. 2007, 51:201-210.
69. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48:4827-4833.
70. Solioz M., Vulpe C. CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem. Sci. 1996, 21:237-241.
71. Strozyk D., Launer L.J., Adlard P.A., Cherny R.A., Tsatsanis A., Volitakis I., Blennow K., Petrovitch H., White L.R., Bush A.I. Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol. Aging 2009, 30:1069-1077.
72. Stuerenburg H.J. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J. Neural Transm. 2000, 107:321-329.
73. Tapia L., Suazo M., Hodar C., Cambiazo V., Gonzalez M. Copper exposure modifies the content and distribution of trace metals in mammalian cultured cells. Biometals 2003, 16:169-174.
74. Tapiero H., Tew K.D. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed. Pharmacother. 2003, 57:399-411.
75. Tiffany-Castiglion E., Qian Y. Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 2001, 22:577-592.
76. Van den Berg G.J., de Goeij J.J., Bock I., Gijbels M.J., Brouwer A., Lei K.Y., Hendriks H.F. Copper uptake and retention in liver parenchymal cells isolated from nutritionally copper-deficient rats. J. Nutr. 1991, 121:1228-1235.
77. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 1999, 6:221-230.
78. Waggoner D.J., Drisaldi B., Bartnikas T.B., Casareno R.L., Prohaska J.R., Gitlin J.D., Harris D.A. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 2000, 275:7455-7458.
79. Wyman S., Simpson R.J., McKie A.T., Sharp P.A. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett. 2008, 582:1901-1906.
80. Zimnicka A.M., Maryon E.B., Kaplan J.H. Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis. J. Biol. Chem. 2007, 282:26471-26480.